FDA halts use of antibody drugs that don’t work vs. omicron

Jan 24, 2022, 3:19 PM | Updated: Jan 25, 2022, 2:10 pm

WASHINGTON (AP) — COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don’t work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.

The Food and Drug Administration said it was revoking emergency authorization for both drugs, which were purchased by the federal government and have been administered to millions of Americans with COVID-19. If the drugs prove effective against future variants, the FDA said it could reauthorize their use.

The regulatory move was expected because both drugmakers had said the infusion drugs are less able to target omicron due to its mutations. Still, the federal action could trigger pushback from some Republican governors who have continued promoting the drugs against the advice of health experts.

Omicron’s resistance to the two leading monoclonal antibody medicines has upended the treatment playbook for COVID-19 in recent weeks.

Doctors have alternate therapies to battle early COVID-19 cases, including two new antiviral pills from Pfizer and Merck, but both are in short supply. An antibody drug from GlaxoSmithKline that remains effective also is in short supply.

The drugs are laboratory-made versions of virus-blocking antibodies. They are intended to head off severe disease and death by supplying concentrated doses of one or two antibodies early in an infection. Then-President Donald Trump received Regeneron’s antibody combination after he tested positive for the coronavirus in 2020.

The FDA noted in its decision that omicron accounts for more than 99% of U.S. infections, making it “highly unlikely” the antibodies would help people now seeking treatment. The agency said restricting their use would also eliminate unnecessary drug side effects, including allergic reactions.

The U.S. government temporarily stopped distributing the two drugs in late December, as omicron was racing across the country to become the dominant variant. But officials resumed distribution after complaints from Republican governors, including Florida’s Ron DeSantis, who claimed that the drugs continued to help some omicron patients.

DeSantis has heavily promoted antibody drugs as a signature part of his administration’s COVID-19 response, setting up infusion sites and lauding them at news conferences, while opposing vaccine mandates and other public health measures. Texas Gov. Greg Abbott has also launched state-sponsored infusion sites.

The drugs are not a substitute for vaccination and are generally reserved for people who are the most vulnerable, including seniors, transplant recipients and those with conditions like heart disease and diabetes.

Since early January, the U.S. government has shipped enough doses of the two antibodies to treat more than 300,000 patients.

Both Regeneron and Lilly previously announced they were developing new antibodies that target omicron.

The move comes days after regulators broadened the use of remdesivir — the first drug approved for COVID-19 — to treat more patients.

On Friday, the FDA expanded the antiviral’s approval to include adults and children with early COVID-19 who face a high risk of ending up in the hospital. Remdesivir previously had been limited to hospitalized patients.

An influential panel of federal experts had already recommended using the infused drug to try to head off hospitalization. The same guidelines from the National Institutes of Health panel recommend against continued use of Lilly and Regeneron’s antibody drugs due to their reduced effectiveness against omicron.

Still, many hospitals will face challenges in ramping up remdesivir treatments. The drug requires three consecutive IV infusions over three days, when used for nonhospitalized patients. That time-consuming process won’t be an option for many over-capacity hospitals facing staff shortages.

The FDA made its decision based on a 560-patient study that showed a nearly 90% reduction in hospitalizations when remdesivir is given within seven days of symptoms. The study predates the omicron variant but, like other antivirals, remdesivir is expected to maintain its performance against the latest variant.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

FILE - Hells Angels founder Ralph "Sonny" Barger and his wife Sharon are shown after his release on...
Associated Press

Sonny Barger, figurehead of Hells Angels, dies at 83

LIVERMORE, Calif. (AP) — Sonny Barger, the leather-clad figurehead of the notorious Hells Angels motorcycle club, has died. He was 83. Barger’s death was announced on his Facebook page late Wednesday. “If you are reading this message, you’ll know that I’m gone. I’ve asked that this note be posted immediately after my passing,” a posting […]
13 hours ago
Associated Press

2nd visitor in 3 days gored by Yellowstone park bison

YELLOWSTONE NATIONAL PARK, Wyo. (AP) — For the second time in three days, a visitor to Yellowstone National Park was gored by a bison, park officials said Thursday. A 71-year-old woman from West Chester, Pennsylvania and her daughter inadvertently approached the bison Wednesday as they were returning to their vehicle at a Yellowstone Lake trailhead. […]
13 hours ago
Associated Press

New York lawmakers to vote on new gun rules following ruling

ALBANY, N.Y. (AP) — New York lawmakers plan to vote Thursday on legislation seeking to limit the proliferation of firearms in public after the Supreme Court gutted the state’s century-old handgun licensing law. The state is overhauling its rules for carrying guns after the court decided that ordinary citizens had a right to arm themselves […]
13 hours ago
New York Lt. Gov. Antonio Delgado ,left, greets legislators before presiding over the Senate during...
Associated Press

New York lawmakers to vote on new gun rules following ruling

ALBANY, N.Y. (AP) — New York lawmakers plan to vote Thursday on legislation seeking to limit the proliferation of firearms in public after the Supreme Court gutted the state’s century-old handgun licensing law. The state is overhauling its rules for carrying guns after the court decided that ordinary citizens had a right to arm themselves […]
13 hours ago
Brooke Davis, photographed Thursday, June 30, 2022 in McDonough, Ga., has been struggling with medi...
Associated Press

Some medical debt is being removed from US credit reports

Help is coming for many people with medical debt on their credit reports. Starting Friday, the three major U.S. credit reporting companies will stop counting paid medical debt on the reports that banks, potential landlords and others use to judge creditworthiness. The companies also will start giving people a year to resolve delinquent medical debt […]
13 hours ago
The New York Stock Exchange on Wednesday, June 29, 2022 in New York. Americans with stock portfolio...
Associated Press

From stocks to crypto, a punishing six months for investors

Americans with stock portfolios or retirement investment plans would likely prefer to forget the last six months. The S&P 500, Wall Street’s broad benchmark for many stock funds, was on pace Thursday afternoon for a 20% loss through the end of June after starting the year at an all-time high. It’s the worst start to […]
13 hours ago

Sponsored Articles

...
Day & Night Air Conditioning, Heating and Plumbing

Most plumbing problems can be fixed with regular maintenance

Instead of waiting for a problem to happen, experts suggest getting a head start on your plumbing maintenance.
...
Carla Berg, MHS, Deputy Director, Public Health Services, Arizona Department of Health Services

Vaccines are safe if you are pregnant or breastfeeding

Are you pregnant? Do you have a friend or loved one who’s expecting?
...
Christina O’Haver

BE FAST to spot a stroke

Every 40 seconds—that’s how often someone has a stroke in the United States. It’s the fifth leading cause of death among Americans, with someone dying of a stroke every 3.5 minutes.
FDA halts use of antibody drugs that don’t work vs. omicron